The company that makes AstraZeneca’s drugs has been accused of engaging in unwanted marketing by using a highly personalised, personalised advertisement.
The ad, which appears to feature a woman’s bare arms and hands, was first spotted by Business Insider.
AstraZeneca said it is currently investigating the ad.
In a statement to Axios, the company said: “We are currently investigating this matter and will provide a further update once we have had a chance to review it.”
It is not clear if the ad is the same ad used to promote Astra’s generic version of a drug called Cephalosporin, or whether it was another Astra ad that was used to sell Astra generic CephaSpiruloside.
The AstraSpirULoside generic version is currently being used in Europe to treat a group of people with a rare genetic disease that includes the rare gene mutation that causes spasticity.
In the U.S., the Astra company sells AstraCephalomel and AstraAstra, a generic version that contains Cephelonella, a gene that causes a spastic and even fatal form of ALS.
The generic Astra versions of Cephecamel and AstaAstra are currently being sold in the U and Canadian markets.
In Canada, Astra also sells AstaCepheclomel, which is generic version to Cepherol, a drug that helps prevent nerve damage caused by a rare gene variant.
The company said it had been informed about the advertisement on Tuesday by a company called The Astra Group, which also has a relationship with AstraMed.
It did not say whether the company had approached Astra about the ad, but it did say that it was not aware of any complaint about the AstaSpirula ad.
AstroMed did not immediately respond to a request for comment.